MRD testing is crucial for high-risk MM patients, aiding in early detection and treatment decisions, despite logistical and insurance barriers. Physicians primarily use MRD to monitor remission, ...

MRD refers to cancer cells remaining post-treatment, undetectable by standard imaging, indicating potential recurrence risk. MRD testing methods include flow cytometry and genetic tests, offering ...

Molecular residual disease, or MRD, testing is emerging as a powerful tool in breast cancer, offering new visibility into what traditional imaging cannot detect. 1 MRD tests, like the Oncodetect® test ...

Here’s how uMRD and CLL prognosis are linked, how doctors test for uMRD, and what achieving undetectable MRD means for your ...

Clinicians have long relied on clinical risk factors, imaging, and pathology to guide cancer surveillance and adjuvant treatment. However, even after curative-intent surgery and definitive therapy, ...

The firm began its early-access program in breast cancer in March and is now expanding the test's indications to include colorectal and renal cancers.

The clearance gives New York clinicians access to the Haystack MRD assay, which detects residual or recurring solid tumour ...

Marks third NCCN guideline recommendation on ctDNA-MRD testing, following positive guideline changes in merkel cell carcinoma and diffuse large b-cell lymphoma Natera, Inc. (NASDAQ: NTRA), a global ...

Myriad Genetics will present new data on its Precise MRD test for renal cell carcinoma at the AACR Annual Meeting. Myriad Genetics, Inc. announced that it will present new clinical data on its Precise ...

Add Yahoo as a preferred source to see more of our stories on Google. Haystack Oncology focuses on advancing liquid biopsy technologies. Credit: Gorodenkoff ...